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Abstract
Background: Buruli ulcer may induce severe disabilities impacting on a person’s well-being and quality of life. Information
about long-term disabilities and participation restrictions is scanty. The objective of this study was to gain insight into
participation restrictions among former Buruli ulcer patients in Ghana and Benin.
Methods: In this cross-sectional study, former Buruli ulcer patients were interviewed using the Participation Scale, the Buruli
Ulcer Functional Limitation Score to measure functional limitations, and the Explanatory Model Interview Catalogue to
measure perceived stigma. Healthy community controls were also interviewed using the Participation Scale. Trained native
interviewers conducted the interviews. Former Buruli ulcer patients were eligible for inclusion if they had been treated
between 2005 and 2011, had ended treatment at least 3 months before the interview, and were at least 15 years of age.
Results: In total, 143 former Buruli ulcer patients and 106 community controls from Ghana and Benin were included in the
study. Participation restrictions were experienced by 67 former patients (median score, 30, IQR; 23;43) while 76 participated
in social life without problems (median score 5, IQR; 2;9). Most restrictions encountered related to employment. Linear
regression showed being female, perceived stigma, functional limitations, and larger lesions (category II) as predictors of
more participation restrictions.
Conclusion: Persisting participation restrictions were experienced by former BU patients in Ghana and Benin. Most
important predictors of participation restrictions were being female, perceived stigma, functional limitations and larger
lesions.
Citation: de Zeeuw J, Omansen TF, Douwstra M, Barogui YT, Agossadou C, et al. (2014) Persisting Social Participation Restrictions among Former Buruli Ulcer
Patients in Ghana and Benin. PLoS Negl Trop Dis 8(11): e3303. doi:10.1371/journal.pntd.0003303
Editor: Pamela L. C. Small, University of Tennessee, United States of America
Received January 6, 2014; Accepted September 30, 2014; Published November 13, 2014
Copyright:  2014 de Zeeuw et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the American Leprosy Missions, the Netherlands Organisation for Scientific Research (NWO-VENI grant to YS) and the
Buruli ulcer Groningen Foundation. The funders had no role in study design, data collection and analysis or decision to publish the manuscript. One member of a
funding agency, PS of American Leprosy Missions, played a role in interpretation of the data and preparation of the manuscript.
Competing Interests: I have read the journal’s policy and have the following conflict: PS is the Medical Director of American Leprosy Missions and played a role
in approving the study for funding. There are no products coming from this research and no financial return to ALM. This does not alter our adherence to all PLOS
NTDs policies on sharing data and materials.’’
* Email: j.de.zeeuw@umcg.nl
Introduction
Buruli ulcer (BU) is a skin condition caused by Mycobacterium
ulcerans, which is the third most prevalent mycobacterial disease
in immuno-competent humans, after the diseases caused by
Mycobacterium tuberculosis and Mycobacterium leprae [1]. BU
presents as a small nodule or a plaque sometimes accompanied by
edema. At a later stage, the lesion breaks open with ulceration
typically presenting with undermined edges [2]. The World
Health Organization (WHO) has classified lesions as category I:
lesions cross-sectional diameter of less than 5 cm; as category II:
lesions of 5–15 cm and category III: lesions of .15 cm; category
III also includes lesions on important sites (for example eyes) and
multiple lesions. The exact mode of transmission remains unclear,
though it is generally accepted that infection is associated with
living close to stagnant water [3]. BU has been found in more than
30 countries predominantly with tropical or subtropical climates;
the most burdened region is West Africa. In 2011, Coˆte d’Ivoire,
Ghana and Benin reported the highest numbers of new cases [4].
In Benin, the prevalence varies from 5.4 cases/10,000 to 60.7/
10,000 inhabitants depending on altitude of villages [5] while the
national BU prevalence in Ghana is 20.7 cases/100,000 inhab-
itants [6]. Since 2005, standard medical treatment entails
antimicrobial therapy sometimes complemented with surgery [7].
Prevention of Disability (POD) programs have been developed
by the WHO, which are implemented in endemic countries to
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reduce disabilities. Essential components are wound management,
and positioning and mobilization of the affected extremity.
Nevertheless, studies have revealed that people still develop
physical disabilities such as scarring, contractures, deformities,
and sometimes require amputation [8,9] or are otherwise left with
functional limitations [10,11]. Not only may BU lead to physical
consequences, but also stigmatization is perceived by former BU
patients, even years after healing [12]. Magico-religious ideas on
the cause of BU, fear of contracting the disease and its visible signs
are suggested to be the most important distinctive features of this
stigma [13]. In other stigmatized health conditions such as leprosy
and leishmaniasis, participation restrictions in social life after
treatment are common [14–18]. Participation restrictions are
defined as ‘any problem an individual may experience in
involvement in life situations’ [19]. For example, a person may
encounter restrictions related to employment, meeting new people,
visiting public places or attending social events in the community.
Participants of a qualitative study have expressed that scarring and
physical disabilities as a result of BU disease may result in
problems with marriage and employment [20]. In addition,
community members expressed persisting negative attitudes
towards BU patients resulting in social exclusion as victims are
believed to have no social responsibilities and should be restricted
in attending social events [21]. Social problems are of particular
importance because of their impact on a person’s well-being and
quality of life [22]. The aim of this study was to explore
participation restrictions among former BU patients and to gain
insight into the factors that predict participation restrictions.
Methods
Study population
From January to October 2012 data for this cross-sectional
study were collected in Ghana and Benin. Eligible for inclusion
were former BU patients aged at least 15 years, who were treated
between 2005 and 2011, and whose treatment was completed at
least 3 months before the study commenced. Medical records of
the Centre de De´pistage et de traitement de l’Ulce`re de Buruli de
Lalo in Benin and Agogo Presbyterian Hospital in Ghana were
screened for potential participants. In the absence of an address
system and with no phone numbers recorded, potential partici-
pants had to be sought in the villages. In Benin a high number of
potential participants were found, and therefore primary health
care posts surrounding the hospital were chosen as study sites.
Posts were selected if a high number of cases was found, from the
medical records, in the catchment area of the post and if they were
relatively easy to access (in terms of distance and road
circumstances). In Ghana, former BU patients who participated
in another follow-up study of the BURULICO trial in Ghana [23]
were excluded. Healthy community controls without any history of
BU or without a visible disability were recruited from villages
located in the study area. In both countries, we aimed to include at
least 50 healthy controls. Community controls representing the
same age (+5/25 years), female/male ratio and geographical
location as the former BU patients were recruited.
Questionnaires
Socio-demographic factors. To obtain information on
socio-demographic variables a questionnaire was developed
containing questions on current medical status, age, sex, location
of residence, educational level, occupation and living situation.
History of BU disease was traced from the BU01 forms and/or
medical records. A visible deformity was established by the
interviewers before the interview.
Participation restrictions. Participation restrictions were
assessed with the Participation Scale (P-scale). The P-scale consists
of 18 items covering eight major life domains distinguished by the
International Classification of Functioning, Disability and Health
(ICF) [24]. The instrument is generic and uses a peer-comparison
to diminish cultural influences. The participants are asked to
compare themselves to someone who is similar in all social-
cultural, economic and demographic aspects, except for the
disease or disability. Each item entails an objective question
(responses; yes, no, sometimes or not specified, not answered or
irrelevant) and a subjective question to grade participation
restrictions (responses; ‘no problem’ (1)’, ‘small problem’ (2),
‘medium problem’ (3) and ‘a large problem’ (5)). Item scores are
summed for the total score (range 0–90). Higher scores signify
more participation restrictions. The cut-off value, based on local
reference data, for participation restrictions was established to be
12 in the development study [24]. We decided to calculate a cut-
off value, an approach which was recommended for this
instrument, which was developed and validated in other cultural
contexts [24].
Functional limitations. The Buruli Ulcer Functional Lim-
itation Score (BUFLS) [25,26] was employed to establish perceived
functional limitations. Questions aim to gain insight into patients’
perception of ability in 19 daily tasks divided into four groups: food
preparation, personal care, daily work activities and mobility. The
BUFLS uses an ordinal response scale; 0 points reflect an activity is
performed without problems, 1 point indicates an activity is
performed with difficulty and 2 points denote that an activity is
impossible to perform. The total score, ranging from 0 to 100, is
the sum score divided by the maximal score applicable for the
patient and multiplied by 100. Higher scores denote a higher level
of functional limitations.
Perceived stigma: A subset of questions (15 in total) of the
Explanatory Model Interview Catalogue (EMIC) [27] which has
been used earlier [13,28], was used to explore perceived stigma
[29]. Response options are ‘yes’ (3 points), ‘possibly’ (2 points),
‘uncertain’ (1 point) and ‘no’ (0 points). Each question contributes
equally to the sum score. Sensitive questions concerning marriage,
sexual functioning and fertility were not asked to participants
below the age of 20 years. To compensate for items not asked, the
Author Summary
Disabilities among Buruli ulcer patients remain a problem.
Previous studies revealed contractures, deformities and
functional limitations in daily life after treatment. Accord-
ing to the International Classification of Functioning,
Disability and Health, disabilities occur not only at the
physical and activity level but at the participation level
(participation restrictions) as well. The latter are the social
consequences of the disease such as problems in
relationships, going to festivals and visiting public places.
This study focused on participation restrictions by using
the Participation Scale among former Buruli ulcer patients
and healthy persons residing in two areas endemic for
Buruli ulcer in Ghana and Benin. This study showed that
almost half of the former Buruli ulcer patients encountered
problems in social life, especially related to employment. In
addition, the results suggest that being female, perceived
stigma, functional limitations and a larger lesion (category
II) predict participation restrictions. These findings indicate
that rehabilitation programs should not only focus on
physical disabilities but also on participation after com-
pletion of medical treatment.
Participation Restrictions in Former BU Patients
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total stigma score was calculated as the percentage of the
maximum score a participant could receive on the questions
applicable for that participant. Higher scores are indicative of a
higher level of perceived stigma.
Translation
Procedures regarding translation of the P-scale are extensively
described elsewhere [30] briefly summarized the scale was
translated and back translated into Twi (language in Ghana) and
French (Benin).
Procedures
Before data collection, in each country two native language
speaking interviewers participated in a training to prevent bias
during the interview. The training was provided using the
available manuals; the Participation Scale Users Manual (version
6.0) and the BUFLS Manual (2012). During data collection
regular discussions were held to reveal difficulties encountered
during interviewing. During the interviews no specific problems
were encountered with understanding the peer comparison.
Former patients with BU were identified with either the assistance
of a BU coordinator, a health care worker, or one of the local
community volunteers. If eligible former BU patients could not be
found or appeared not to be in the village, a second visit was
planned to ask for study participation. To ensure privacy during
the interviews, private quiet places were used to conduct the
interview.
Ethical consent
Ethical approval was granted by the Medical Ethical Review
Committees of the Kwame Nkrumah University of Science and
Technology, School of Medical Sciences, Komfo Anokye Teach-
ing Hospital in Ghana (ref: CHRPE/RC/127/12) and the
Ministry of Health in Benin (ref: N01961/MS/DC/SGM/
DRF/SRAO/SA). Adult participants provided written informed
consent. A parent or guardian of any child participant provided
informed consent on their behalf.
Statistical analysis
Data analyses were performed with Statistical Package for the
Social Science (SPSS) version 20.0. The cut-off for the P-scale
scores was determined calculating the 95th percentile of the P-
scale sum scores of healthy community controls [24]. Two outliers
in Ghana were removed for this analysis. The resulting cut-off was
16, indicating that participants with scores up to 16 were
categorized as not having participation restrictions and partici-
pants with scores 17 or higher were categorized as having
participation restrictions. Basic features of the data were analyzed
using descriptive statistics. As appropriate, Pearson’s chi-square
test, Fisher’s exact test, Mann-Whitney U test, Kruskal-Wallis test
and Spearman Ranks correlation were performed to compare for
differences in socio-demographic factors and clinical aspects across
countries as well as for univariate associations with P-scale sum
scores. Factors significantly related (P,0.1) to P-scale sum scores
were entered as potential predictors of participation restrictions in
a linear regression analysis. Residuals were checked for a normal
distribution. The variable: ‘visible deformity‘ was removed for
analysis because of missing values (n=41). Predictors were
removed from the model when removal criterion was met
(P.0.1). Interaction terms (country x sex, sex x stigma scores,
sex x age, and country x stigma score) were explored, also using
differences found in the previous analysis [30] between Ghana and
Table 1. Characteristics of former BU patients.
Variables Ghana (n=75) Benin (n=68) P-value
Age at time of inclusion, median (IQR) 27 (19;33) 25 (18;43) .791*
Sex (male, %) 33 (44) 31 (46) .859`
Length of time since start treatment, median in months
(IQR)
24 (15;37) 62 (33;71) ,.001*
Type of treatment Antibiotic treatment, n (%) 55 (73) 29 (43) ,.001`
Antibiotics and surgery, n (%) 20 (27) 39 (57)
Nr. of lesions, n (%) 1 68 (91) 61 (91) .938`
.1 7 (9) 6 (9)
Lesion size, n (%) Category I 56 (82) 36 (53) .001`
Category II 8 (12) 19 (28)
Category III 4 (6) 13 (19)
Type of lesion Nodule 31 (41) 2 (3) ,.001`
Plaque/edema 19 (26) 18 (26)
Ulcer 25 (33) 48 (71)
Joint involved (yes, %) 24 (36) 27 (42) .455`
Visible deformity (yes, %) 1 (2) 17 (32) ,.001`
Profession, n (%) Employed/student 74 (99) 60 (88) .010`
Unemployed 1 (1) 8 (12)
Living situation, n (%) Living with nuclear family 30 (40) 17 (25) .011`
Living with extended family 41 (55) 51 (75)
With others 4 (5) 0
*Mann Whitney U test, `Pearson chi-square or Fisher’s exact test as appropriate.
doi:10.1371/journal.pntd.0003303.t001
Participation Restrictions in Former BU Patients
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Benin. For interpretability, age was centered at 15 years as
minimum age of the BU patients was 15 years of age.
Results
Population
In total 121 patients were treated for BU in Agogo Presbyterian
Hospital in Ghana between 2005 and 2011 of which 46 could not
be found. Reasons were unknown addresses (20), unclear
information on name or location (16), had died (6) or were not
traced (4) resulting in participation of 75 former patients with BU
in Ghana. In Benin, a total of 4 village health centers were visited
resulting in 255 patients treated for BU between 2006 and 2011.
In total 68 former patients with BU could be traced. Reasons why
patients could not be found were not recorded. Significant
differences between Ghana and Benin were found in length of
time since start of treatment, type of treatment, lesion size, type of
lesion, visible deformity, profession, and living situation (Table 1).
Profile of participation restrictions
Using a cut-off value of 16, in total, 67 (47%) former patients
with BU experienced participation restrictions (median 30, IQR;
23; 43) while 76 indicated no participation problems (median 5,
IQR; 2;9). Median P-scale sum scores of the former BU patients
were similar in Ghana and Benin (Ghana: median 13, IQR; 5;29,
Benin: median 13, IQR; 4;30). Across both countries, the most
frequently reported problems among former BU patients were
related to employment. In addition, in Ghana former BU patients
experienced mainly problems with meeting new people, giving
their opinion in family discussions, long-term relationships, being
socially active, respect, and recreational and social activities. In
Benin, former BU patients experienced mainly problems with
being socially active, giving their opinion in family discussions,
going for visits outside the village, recreational/social activities,
helping others, and attending major festivals and rituals. Patients
in Ghana had higher scores on each item compared to the healthy
community controls, except for doing household work and
confidence to learn new things. In addition healthy community
controls in Ghana had higher levels of participation restrictions
compared to healthy controls in Benin (Figure 1 and 2).
To illustrate, a former BU patient expressed her aspiration to be
the teacher of a local woman’s group, but because of BU she could
not effectively organize the group. Another patient expressed his
wish to be the leader of his political party in the future but he did
not have enough money and because of the condition he could not
succeed.
Basic factors, functional limitations, perceived stigma and
participation restrictions
In Benin, women, or patients with more than 1 lesion, a visible
deformity or larger lesions scored significantly higher on the P-
scale (Table 2). Furthermore, a median EMIC score of 19.5 (IQR;
10;36) was reported; women scored a median score of 19 (IQR;
9;36) and men 21.4 (IQR; 11;37). The median BUFLS was 7.9
(IQR; 0;20) and women (median 18, IQR; 3;24) scored
significantly (P= .009) higher compared to men (median 0, IQR;
0;16). In Ghana, a median EMIC score of 20 (IQR; 13;53) was
found; women scored a median score of 21.1 (IQR; 9;54) and men
20 (IQR; 13;54). The median BUFLS was 6.7 (IQR; 0;16) and
women (median 11.8, IQR; 3;19) scored significantly (P= .043)
higher compared to men (median 2.6, IQR; 0;13).
Predictors of participation restrictions
Factors significantly contributing to the regression equation
were sex, functional limitations (BUFLS), perceived stigma
(EMIC), age and lesion size (Table 3). The explained variance of
the model was 52%. In the prediction model, females had on
average higher (8.1) P-scale scores than men. As functional
limitation increases by 1 point, (scale range 0–71), P-sale score
increases on average with 0.6 units. As perceived stigma increases
by 1 point, (scale range 0–90), P-scale score increases on average
with 0.2 units. Having a category II lesion (cross-sectional
diameter of 5–15 cm) increases the P-scale score on average with
7.6 points.
Post hoc analysis was performed to determine predictive value
of lesion size as dichotomized variable (category I vs category II
and III) on participation restrictions. Factors significantly contrib-
uting to the regression equation were similar as shown in Table 3
as well as the explained variance of the model. Having a category
II or III lesion increases the P-scale score by 6.8 points (P= .010).
Figure 1. Profile of participation restrictions of patients and controls in Ghana. Red bar: patients. Blue bar: healthy community controls.
doi:10.1371/journal.pntd.0003303.g001
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Discussion
We showed persisting participation restrictions in almost half of
the former patients with BU in Ghana and Benin. The percentage
of former patients with BU with participation restrictions is less
compared to previous studies among former leprosy patients
positively screened for difficulties in functioning in Indonesia
(about 60%) [18], but is higher compared to former leprosy
patients in Bangladesh (34%) [17] and Brazil (35%) [16]. Most
commonly reported problems as indicated by former BU patients
related to employment. This is in line with a previous study on
participation restrictions using the P-scale among a total of 20
leprosy affected persons in Nigeria [14] reporting problems in
areas related to work, domestic life and interpersonal relations.
And a study among recently diagnosed leprosy patients in India
showed that many respondents experience restrictions in areas
related to work [31]. Finally the results of our study confirm
qualitative findings reporting that BU may cause problems with
employment [20]. The other areas in which former BU patients
experienced restrictions differed between Ghana and Benin.
Predictors of participation restrictions were sex, perceived stigma,
functional limitations and the size of the lesion. Women were more
at risk for participation restrictions, which may be explained by
sociocultural perception differences on participation restrictions
between men and women. Further the difference can be explained
by a different experience of the negative attitudes of community
members as indicated in a previous study [21]. Furthermore it is
plausible that women have more tasks and relationships as
compared to men, however in Indonesia no difference in
participation restrictions between men and women was found
[18]. Patients affected by larger lesions may lose more muscle or
joint function and as a result are more restricted in participation.
In addition functional limitations may also affect people’s mobility
to participate in their community. Finally feeling stigmatized as a
result of being a former BU patient may prevent people to interact
with others in and outside the community or participate in
relationships.
To our knowledge, this study was the first to use a prediction
model for participation restrictions among former patients with
BU as measured with the P-scale. Surprisingly duration between
end of treatment and time of interview did not influence
participation restrictions. In addition participation restrictions
were not significantly different for category III lesions compared to
category I lesions. It is plausible that the small sample size of
former patients with BU with category III lesions resulted in this
outcome. Therefore we performed a post hoc analysis dichoto-
mizing small lesions (category I) and large lesions (category II and
III). The results of this analysis showed that having a category II or
III lesion increases the P-scale score by 6.8 points.
To establish cut-off scores the 95th percentile of the community
scores was calculated. Two healthy community controls from
Ghana were removed for this analysis because they presented
extreme outliers, affecting cut-off tremendously (29 versus 14). The
cut-offs varied slightly for Ghana and Benin (18 versus 14)
indicating heterogeneity across countries. Though, we decided to
calculate 1 cut-off as preferred for future use in the field.
Several study limitations should be mentioned. The groups of
BU patients in Ghana and Benin were heterogeneous as many
factors such as case finding activities and exclusion of potential
participants due to participation in another study were beyond our
control. As a result, former patients in Ghana were treated much
more recently and mainly had category I lesion. Furthermore
differences regarding employment related problems were found.
However background information regarding these differences is
not available as it was not the focus of our study, also because we
did not expect these differences. In Benin, we aimed for random
sampling of the potential participants, however, logistical reasons
led to the decision for a convenience sample in certain villages. It is
conceivable that selection bias may have occurred. Furthermore,
the cross-sectional design of the study prohibits drawing causal
relationships. As such, some of the statistical predictors (perceived
stigma and functional limitations) of participation restrictions may
also be a result of participation restrictions. This is in line with the
ICF model encompassing all the dimensions of disability, showing
solely bidirectional associations. Finally, due to unknown reasons
visible deformity was filled out less frequently leading to missing
data and its influence on the P-scale could therefore not be
analyzed in the linear regression.
To conclude, we have shown persisting participation restrictions
among former patients with BU, even long after treatment had
finished and wounds had healed. Unfortunately the introduction
of the antibiotic treatment in 2005 has not been able to prevent
Figure 2. Profile of participation restrictions of patients and controls in Benin. Red bar: patients. Blue bar: healthy community controls.
doi:10.1371/journal.pntd.0003303.g002
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long-term consequences on the capability to participate in the
community. The results indicate active case finding is required, as
former patients with BU that presented with small lesions
experienced less participation restrictions. POD programs, includ-
ing stigma reduction strategies and physical and social rehabili-
tation are needed even after ‘successful’ completion of medical
treatment. Such programs should pay extra attention to work
integration. Before the development of these POD programs
mixed methods studies should be performed to study local
meanings of participation restrictions.
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